Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Study design and timing

TB Tessy Boedt
NW Nele Willaert
SF Sharon Lie Fong
ED Eline Dancet
CS Carl Spiessens
FR Filip Raes
CM Christophe Matthys
KG Katleen Van der Gucht
request Request a Protocol
ask Ask a question
Favorite

The MoMiFer-randomised controlled trial (RCT) is an exploratory study.36 This trial uses a parallel group design, with allocation ratio 1:1. The experimental group has immediate access to the MoMiFer-app for 3 months. The control group is wait-listed for 3 months after which access to the MoMiFer-app is received. The MoMiFer-study is a repeated measures design and will result in 3 waves of time-series data for each participant. Recruitment through open enrolment started on 24 November 2019. Figure 1 presents an overview of the study design.

Overview of the MoMiFer-RCT. ESM, experience sampling method; QOL, quality of life; RCT, randomised controlled trial.

Copyright and License information:  ©2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A